# Vitamin D and Grass Pollen Specific Immunotherapy

> **NCT01466465** · PHASE2 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 35 (actual)

## Conditions studied

- Allergic Rhinoconjunctivitis

## Interventions

- **DRUG:** Cholecalciferol
- **OTHER:** middle-chain fatty acids (carrier)

## Key facts

- **NCT ID:** NCT01466465
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2015-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466465, "Vitamin D and Grass Pollen Specific Immunotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01466465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*